Studies on the PEGylation of human serum albumin and the vascular permeability as well as pharmacokinetics of pegylated derivatives

ZHAO Ting,YANG Yang,SONG Xin-lei,HUANG Xiao-jing,WANG Feng-shan
2012-01-01
Abstract:Purpose To decrease the capillary permeability and improve the intravascular retention of HSA.Methods HSA was PEGylated by cyanuric chloride activated PEG.The secondary structure of PEG-HSA was characterized by circular dichroism measurement.The vascular permeability of PEG-HSA was investigated in acute lung injury mouse model and the pharmacokinetics study was conducted in mice.Results The secondary structure of PEG-HSA was almost identical to that of native HSA.PEG-HSA had a lower vascular permeability than HSA,and the biological half-life of PEG-HSA was approximately 2.2 times of that of the native HSA.Conclusion PEGylated HSA is superior to HSA in treating illness related to the capillary permeability increase because of its longer biological half-life and lower vascular permeability.
What problem does this paper attempt to address?